Related Experiment Video
Updated: Dec 6, 2025

Intra-Arterial Delivery of Neural Stem Cells to the Rat and Mouse Brain: Application to Cerebral Ischemia
Published on: June 26, 2020
Neurovascular complications that can be seen in COVID-19 patients
Shingo Kihira1, Javin Schefflein1, Puneet Pawha1
1Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, Box 1234, New York, NY 10029, USA.
Insights
COVID-19 patients exhibit a hypercoagulable state, increasing risks for blood clots. This study highlights cases of head and neck arterial and venous thrombosis in individuals with SARS-CoV-2 infection.
Area of Science:
- Internal Medicine
- Infectious Diseases
- Cardiology
Background:
- Coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2, is a global pandemic.
- A hypercoagulable state is a recognized complication of SARS-CoV-2 infection.
- Previous reports have documented various thrombotic events, including pulmonary and abdominal vascular occlusions.
Observation:
- This study focuses on thrombosis specifically within the head and neck region.
- Cases of both arterial and venous thrombosis in the head and neck were observed in COVID-19 patients.
- The clinical presentation and outcomes of these specific thrombotic events are detailed.
Findings:
- COVID-19 is associated with an increased risk of arterial and venous thrombosis in the head and neck.
- These thrombotic events can manifest in various vessels within the head and neck region.
- Early recognition and management of thrombosis are crucial for patients with SARS-CoV-2 infection.
Implications:
- Understanding the spectrum of thrombotic complications in COVID-19 is essential for clinical management.
- Head and neck thrombosis should be considered in the differential diagnosis of neurological or vascular symptoms in COVID-19 patients.
- Further research is needed to elucidate the mechanisms and optimize treatment strategies for COVID-19-related thrombosis.
Abstract:
Coronavirus disease 2019 (COVID-19), a clinical manifestation of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), was declared a global pandemic by the World Health Organization on March 11, 2020. Hypercoagulable state has been described as one of the hallmarks of SARS-CoV-2 infection and has been reported to manifest as pulmonary embolisms, deep vein thrombosis, and arterial thrombosis of the abdominal small vessels. Here we present cases of arterial and venous thrombosis pertaining to the head and neck in COVID-19 patients.
Related Concept Videos
Local Anesthetics: Adverse Effects
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
Peripheral Artery Disease V: Postoperative Nursing Management
Peripheral Artery Disease IV: Nursing Management
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Disorders of the Autonomic Nervous System
Raynaud's disease, also known as Raynaud's...
Pneumonia III: Complications and Assessment

